Pharmacist tells KSL most online peptides fail identity testing
Phil Cowley cites a study of 2,600 peptides bought online in which 61% were not what the label claimed, and says BPC-157 human data remain minimal.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 1 15:10 ETSource: ksl.com
The wire
- 01Pharmacist Phil Cowley said a study of 2,600 peptides purchased online found 61% were not as labeled, and that human trials of BPC-157 and TB-500 involved only two people.
- 02Clinicians fielding questions about the BPC-157 plus TB-500 stack, GHK-Cu, CJC-1295, tesamorelin and ipamorelin get a plain-language framing of the gray-market sourcing risk.
- 03Cowley said GHK-Cu evidence is largely topical rather than injectable; the segment is a consumer explainer, not new data, and the cited study is not identified by name.
From the source
Read at ksl.comPeptides: Do you actually need them? A pharmacist's honest opinion on popular options
SALT LAKE CITY — It's the hushed conversation happening between sisters, neighbors and girlfriends. Suddenly, it feels like everybody's talking about peptides.
